IMIM - Institut Hospital del Mar d'Investigacions Mèdiques IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

News

  • 04/03/2021 - Covid-19

    Administering zinc to covid-19 patients could help towards their recovery

    Administering zinc supplements to covid-19 patients with low levels of this element may be a strategy to reduce mortality and recovery time. At the same time, it could help to prevent risk groups, like the elderly, from suffering the worst effects of the disease. These are the findings of a study by physicians and researchers from the Hospital del Mar, Hospital del Mar Medical Research Institute (IMIM) and Pompeu Fabra University (UPF), led by Dr. Robert Güerri, a physician at the Infectious Diseases Service of Hospital del Mar, which has just been published in the journal Nutrients. The study analysed the zinc levels of 249 adult patients treated at the centre between 9 March and 1 April 2020, with an average age of 65 years. The most common symptoms presented at the time of admission were fever, cough and dyspnea.

    Més informació "Administering zinc to covid-19 patients could help towards their recovery"

  • 18/02/2021 - Covid-19

    Immunoglobulin clinical trial launched to prevent COVID-19 side effects

    The Hospital del Mar Medical Research Institute (IMIM), Hospital del Mar, the University of California-Davis and the University of Texas have launched a clinical trial to analyse how useful a food supplement can be for preventing the worst side effects of COVID-19. The study is looking at bovine-derived immunoglobulins, which have been shown in animal models to reduce the inflammation caused by infection, progression to more severe forms of the disease, and post-COVID syndrome. The first patients participating in the Randomized Open-Label Clinical Study Evaluating the Impact of EnteraGam, a Nutritional Intervention containing Bovine Plasma-Derived Immunoglobulin CoNcentrate, on Clinical Outcomes In People with COVID19 (PICNIC Study) are already taking two daily doses of this supplement. Dr Robert Güerri, principal investigator in the trial, member of the Infectious Pathology and Antimicrobial Research Group at the IMIM-Hospital del Mar, and section head of the Infectious Diseases Service at Hospital del Mar, explains that "The aim of the treatment is to sequester and help eliminate the virus from one of its main reservoirs in the body, the gut."

    Més informació "Immunoglobulin clinical trial launched to prevent COVID-19 side effects"

  • 15/12/2020 - Press release

    The presence of COPD, a determining factor in lung cancer treatment

    DNA damage levels and the activity of the polymerase enzyme responsible for cell repair (PARP) increase in lung tumours in patients suffering chronic obstructive pulmonary disease (COPD), but not in people who do not have this pathology. This is reflected in work by researchers from the CIBER of Respiratory Diseases (CIBERES) and doctors and researchers from the Hospital del Mar Pneumology Service and the Hospital del Mar Medical Research Institute research group on muscle wasting and cachexia in chronic respiratory diseases and lung cancer (IMIM-Hospital del Mar), published in the journal Cancers This research is of enormous importance given that treating lung cancer with PARP enzyme inhibitors (already in clinical use for other tumours, such as breast and ovarian cancers) is preferentially indicated for patients with an underlying respiratory disease, while the response in people with no COPD is highly controversial.

    Més informació "The presence of COPD, a determining factor in lung cancer treatment"

  • 17/11/2020 - Press release

    Nutritional parameters of lung cancer and COPD patients could predict their 10-year survival rate

    Nutritional parameters such as body mass index and tests including albumin and total protein levels quantified prior to lung cancer surgery in patients with chronic obstructive pulmonary disease (COPD) predict their 10 year survival, regardless of tumour-related factors and/or chest surgery. This is reflected in the work of researchers from the CIBER of Respiratory Diseases (CIBERES) and doctors and researchers from the Hospital del Mar Pneumology Service and the Hospital del Mar Medical Research Institute research group on muscle wasting and cachexia in chronic respiratory diseases and lung cancer (IMIM-Hospital del Mar), published in the journal of the Spanish Society of Pneumology and Thoracic Surgery (SEPAR)  Archivos de Bronconeumología. The researchers studied the nutritional status of lung cancer and COPD patients who required surgery and the relationship of this with post-operative survival.  To do this, they analysed the nutritional status of 125 patients from Hospital del Mar, 87 of whom had COPD and lung cancer and 38 of whom had cancer but no COPD, before they underwent chest surgery. The patients were monitored for 10 years in order to study their differential survival rates according to the presence or absence of COPD.

    Més informació "Nutritional parameters of lung cancer and COPD patients could predict their 10-year survival rate"

  • 03/11/2020 - Covid-19

    Some of the principal treatments for osteoporosis could reduce the incidence of COVID-19

    Some of the principal treatments for osteoporosis, denosumab, zoledronate and calcium, could have a protective effect against COVID-19 in patients who take them, specifically a 30 to 40% reduction in the rate of infection, according to the results of a joint study by Hospital del Mar, the Hospital del Mar Medical Research Institute (IMIM), Pompeu Fabra University and the Pere Virgili Health Park. The study, the first of its kind in the world, has just been published the journal Aging. The last author of the study, Dr. Jordi Monfort, head of Rheumatology at Hospital del Mar and coordinator of the Cell Research on Inflammation and Cartilage research group at Hospital del Mar-IMIM, explains that "there are indications to allow hypothesizing that certain drugs used to treat rheumatic diseases could interfere positively in the natural history of COVID-19, either by decreasing its incidence or by decreasing its progression to more serious cases". The study analysed data from more than 2,000 patients with osteoporosis, osteoarthritis and fibromyalgia and their relationship with COVID-19 infection who are being followed up at Hospital del Mar and in the Mar Health Park healthcare sphere of influence.

    Més informació "Some of the principal treatments for osteoporosis could reduce the incidence of COVID-19"

  • 15/10/2020 - Press release

    Pneumologists from Hospital del Mar recommend improving the therapeutic approach to mild asthma

    They believe that the treatment currently used in many cases, based solely on short-acting bronchodilators like the well-known Ventolin, may increase the risk of severe asthma attacks.  This is revealed by a study published in the journal Archivos de Bronconeumología. They advocate the use of inhaled corticoids, which is also the treatment recommended by the international Global Initiative for Asthma (GINA). Asthma is increasingly prevalent and affects 5-10% of the general population. Unfortunately, the decline in associated mortality has slowed in recent years. In the current context, characterised by the COVID-19 epidemic, there is no evidence that suffering asthma implies a more severe form of COVID-19.

    Més informació "Pneumologists from Hospital del Mar recommend improving the therapeutic approach to mild asthma"

  • 24/07/2020 - Press release

    One call ensures successful colonoscopy

    One simple call to go over colonoscopy preparation instructions 48 hours before an appointment increases test success by 11.5%. This has been demonstrated in a multi-centre study led by doctors and nurses from the Digestive Tract Service at Hospital del Mar and researchers from the Clinical and Translational Research Group on Colorectal Neoplasia at the Hospital del Mar Medical Research Institute (IMIM). The work, published in the journal Endoscopy, analysed data from 657 patients from 11 Spanish hospitals.  This is the first multi-centre study to analyse how an educational approach can improve colon preparation in people at high risk of not achieving this.

    Més informació "One call ensures successful colonoscopy"

  • 27/05/2020 - General information

    Grant from the Spanish Transplant Society for a study by the Nephrology Service

    The Spanish Transplant Society has awarded the SET 2020 grant to intensify the research activity of Dr. María José Pérez Sáez, a consultant in the Nephrology Service and a researcher at the Hospital del Mar Medical Research Institute (IMIM). It is the only grant of this type that the organisation will award this year. The 30,000 euro grant will enable Dr. Pérez Sáez to work on one of the research projects currently underway in the department and IMIM, looking at fragility in the kidney transplant waiting list. The study of fragility in candidates for kidney transplants was launched by the Hospital del Mar's Nephrology Service in 2016, and currently has data from more than 500 patients. After an initial observational phase, in which the data collected will be analysed prospectively, two more phases have been designed: to biochemically characterise the fragile patient's phenotype, for which a biobank of samples has been set up; and a final intervention phase, with a pre-habilitation clinical trial in these patients while they are awaiting a transplant.

    Més informació "Grant from the Spanish Transplant Society for a study by the Nephrology Service"

  • 29/10/2019 - Institutional news

    Living in a noisy area increases the risk of suffering a more serious stroke

    The high levels of environmental noise we are subjected to in large cities can increase both the severity and consequences of an ischaemic stroke. More precisely, researchers from the Hospital del Mar Medical Research Institute (IMIM) and doctors from Hospital del Mar, together with researchers from the Barcelona Institute for Global Health (ISGlobal), CIBER in Epidemiology and Public Health (CIBERESP), and Brown University, in the United States, put the increased risk at 30% for people living in noisier areas. In contrast, living close to green areas brings down this risk by up to 25%. This is the first time that these factors have been analysed in relation to stroke severity. The study has been published in the journal Environmental Research.

    Més informació "Living in a noisy area increases the risk of suffering a more serious stroke"

  • 28/06/2019 - Press release

    Possible marker of treatment resistance in HER2 breast cancer identified

    The ageing of NK lymphocytes circulating in the blood of patients with HER2-positive breast cancer is a marker that can predict the success or failure of monoclonal antibody therapies, which act on a specific factor in tumour cells.  This is the conclusion of a study led by researchers from the Hospital del Mar Medical Research Institute (IMIM) and the Pompeu Fabra University, and doctors from the Hospital del Mar, published in the journal Cancer Immunology Research. The study also involved staff from the Medical Oncology Service at Hospital Clínic in Valencia, the Pathological Anatomy Services at Hospital del Mar, Fundación Jiménez Díaz in Madrid, and the Immunogenetics Service at Puerta de Hierro University Institute, also in Madrid. It involved analysing blood samples from 66 patients, immunogenetic and functional studies of the NK lymphocytes of these patients, as well as analysing tumour biopsies. The ageing of these cells was measured by quantifying the NK lymphocytes in the blood that express the CD57 molecule. The results show that patients with high blood counts at the time of diagnosis are more likely to be resistant to chemotherapy and anti-HER2 antibody treatment. 

    Més informació "Possible marker of treatment resistance in HER2 breast cancer identified"

© Institut Hospital del Mar
d'Investigacions Mèdiques
Legal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact